Tags

Type your tag names separated by a space and hit enter

Cholinergic neuropathology in a mouse model of Alzheimer's disease.
J Comp Neurol 2003; 462(4):371-81JC

Abstract

Transgenic mice overexpressing mutant human amyloid precursor protein (PDAPP mice) develop several Alzheimer's disease (AD)-like lesions including an age-related accumulation of amyloid-beta (Abeta)-containing neuritic plaques. Although aged, heterozygous PDAPP mice also exhibit synaptic and glial cell changes characteristic of AD pathology, no evidence of widespread neuronal loss has been observed. The present study sought to determine whether homozygous PDAPP mice, which express very high levels of Abeta peptide, exhibit AD-like cholinergic degenerative changes, and whether the changes parallel the deposition of Abeta plaques. Mice were examined at 2 and 4 months and at 1 and 2 years of age. There was an age-related increase in the density of Abeta plaques in the cortex and hippocampus of the PDAPP animals; at 4 months of age there were very few plaques, and at 2 years there was a very high density of plaques. There was an age-related reduction in the density of cholinergic nerve terminals in the cerebral cortex; at 2 months there was a normal density of nerve terminals, but as early as age 4 months there was an approximately 50% reduction. However, at age 2 years there was no difference in the number or size of basal forebrain cholinergic somata compared with 2-month-old PDAPP mice. These data indicated that the homozygous PDAPP mouse exhibits cholinergic nerve terminal degenerative pathology and that the cortical neurodegenerative changes occur before the deposition of Abeta-containing neuritic plaques.

Authors+Show Affiliations

Department of Psychiatry, University of Texas Southwestern Medical School, Dallas, Texas 75390-9070, USA. dwight.german@utsouthwestern.eduNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

12811807

Citation

German, Dwight C., et al. "Cholinergic Neuropathology in a Mouse Model of Alzheimer's Disease." The Journal of Comparative Neurology, vol. 462, no. 4, 2003, pp. 371-81.
German DC, Yazdani U, Speciale SG, et al. Cholinergic neuropathology in a mouse model of Alzheimer's disease. J Comp Neurol. 2003;462(4):371-81.
German, D. C., Yazdani, U., Speciale, S. G., Pasbakhsh, P., Games, D., & Liang, C. L. (2003). Cholinergic neuropathology in a mouse model of Alzheimer's disease. The Journal of Comparative Neurology, 462(4), pp. 371-81.
German DC, et al. Cholinergic Neuropathology in a Mouse Model of Alzheimer's Disease. J Comp Neurol. 2003 Aug 4;462(4):371-81. PubMed PMID: 12811807.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Cholinergic neuropathology in a mouse model of Alzheimer's disease. AU - German,Dwight C, AU - Yazdani,Umar, AU - Speciale,Samuel G, AU - Pasbakhsh,Parichehr, AU - Games,Dora, AU - Liang,Chang-Lin, PY - 2003/6/18/pubmed PY - 2003/8/9/medline PY - 2003/6/18/entrez SP - 371 EP - 81 JF - The Journal of comparative neurology JO - J. Comp. Neurol. VL - 462 IS - 4 N2 - Transgenic mice overexpressing mutant human amyloid precursor protein (PDAPP mice) develop several Alzheimer's disease (AD)-like lesions including an age-related accumulation of amyloid-beta (Abeta)-containing neuritic plaques. Although aged, heterozygous PDAPP mice also exhibit synaptic and glial cell changes characteristic of AD pathology, no evidence of widespread neuronal loss has been observed. The present study sought to determine whether homozygous PDAPP mice, which express very high levels of Abeta peptide, exhibit AD-like cholinergic degenerative changes, and whether the changes parallel the deposition of Abeta plaques. Mice were examined at 2 and 4 months and at 1 and 2 years of age. There was an age-related increase in the density of Abeta plaques in the cortex and hippocampus of the PDAPP animals; at 4 months of age there were very few plaques, and at 2 years there was a very high density of plaques. There was an age-related reduction in the density of cholinergic nerve terminals in the cerebral cortex; at 2 months there was a normal density of nerve terminals, but as early as age 4 months there was an approximately 50% reduction. However, at age 2 years there was no difference in the number or size of basal forebrain cholinergic somata compared with 2-month-old PDAPP mice. These data indicated that the homozygous PDAPP mouse exhibits cholinergic nerve terminal degenerative pathology and that the cortical neurodegenerative changes occur before the deposition of Abeta-containing neuritic plaques. SN - 0021-9967 UR - https://www.unboundmedicine.com/medline/citation/12811807/Cholinergic_neuropathology_in_a_mouse_model_of_Alzheimer's_disease_ L2 - https://doi.org/10.1002/cne.10737 DB - PRIME DP - Unbound Medicine ER -